Stereocomplex Poly(lactic acid) Discoidal Microparticles for Sustained Drug Release |
Park, Chaewon
(Department of Biomedical Engineering, Yonsei University)
Park, Sanghyo (Department of Biomedical Engineering, Yonsei University) Kim, Woo Cheol (Department of Biomedical Engineering, Yonsei University) Key, Jaehong (Department of Biomedical Engineering, Yonsei University) |
1 | TGJr CBR. Timeline: chemotherapy and the war on cancer. Nat Rev Cancer. 2005;5:6572. |
2 | Singh RP, Sharma G, Singh S, Bharti S, Pandey BL, Koch B, Muthu MS. Chitosan-folate decorated carbon nanotubes for site specific lung cancer delivery. Materials Science and Engineering: C. 2017;77:446-58. DOI |
3 | Mignani S, Bryszewska M, Klajnert-Maculewicz B, Zablocka M, Majoral J-P. Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report. Biomacromolecules. 2014;16:1-27. DOI |
4 | Perez-Herrero E, Fernandez-Medarde A. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy. European journal of pharmaceutics and biopharmaceutics. 2015;93:52-79. DOI |
5 | Senapati S, Mahanta A.K, Kumar S, Maiti P. Controlled drug delivery vehicles for cancer treatment and their performance. Signal transduction and targeted therapy. 2018;3:7. DOI |
6 | Witharana C, Wanigasekara J. Drug Delivery Systems: A New Frontier in Nano-technology. International Journal of Medical Research & Health Sciences. 2017;6:11-4. |
7 | Langer R. New methods of drug delivery. Science. 1990;249:1527-33. DOI |
8 | Sonali, Agrawal P, Singh RP, Rajesh CV, Singh S, Vijayakumar MR, Pandey BL, Muthu MS. Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. Drug delivery. 2016;23:1788-98. DOI |
9 | Bhirde AA, Patel V, Gavard J, Zhang G, Sousa AA, Masedunskas A, Leapman RD, Weigert R, Gutkind JS, Rusling JF. Targeted killing of cancer cells in vivo and in vitro with EGFdirected carbon nanotube-based drug delivery. ACS nano, 2009;3:307-16. DOI |
10 | Uhrich KE, Cannizzaro SM, Langer RS, Shakesheff KM. Polymeric systems for controlled drug release. Chemical reviews. 1999;99:3181-98. DOI |
11 | Huang X, Brazel CS. On the importance and mechanisms of burst release in matrix-controlled drug delivery systems. Journal of controlled release. 2001;73:121-36. DOI |
12 | Setterstrom JA, Tice TR, Myers WE. Development of encapsulated antibiotics for topical administration to wounds. In Recent advances in drug delivery systems. 1984;185-98. |
13 | Ulery BD, Nair LS, Laurencin CT. Biomedical applications of biodegradable polymers. Journal of polymer science Part B: polymer physics. 2011;49:832-64. DOI |
14 | Ikada Y, Jamshidi K, Tsuji H, Hyon SH. Stereocomplex formation between enantiomeric poly (lactides). Macromolecules. 1987;20:904-6. DOI |
15 | Monticelli O, Putti M, Gardella L, Cavallo D, Basso A, Prato M, Nitti S. New stereocomplex PLA-based fibers: effect of POSS on polymer functionalization and properties. Macromolecules. 2014;47:4718-27. DOI |
16 | Regnell Andersson S, Hakkarainen M, Inkinen S, Sodergard A, Albertsson A-C. Customizing the hydrolytic degradation rate of stereocomplex PLA through different PDLA architectures. Biomacromolecules. 2012;13:1212-22. DOI |
17 | Pastorino L, Dellacasa E, Petrini P, Monticelli O. Stereocomplex poly (lactic acid) nanocoated chitosan microparticles for the sustained release of hydrophilic drugs. Materials Science and Engineering:C. 2017;76:1129-35. DOI |
18 | Xie G, Sun J, Zhong G, Shi L, Zhang D. Biodistribution and toxicity of intravenously administered silica nanoparticles in mice. Archives of toxicology. 2010;84:183-90. DOI |
19 | Almeida JPM, Chen AL, Foster A, Drezek R. In vivo biodistribution of nanoparticles. Nanomedicine. 2011;6:815-35. DOI |
20 | Sarparanta M, Bimbo LM, Rytkonen J, Makila E, Laaksonen TJ, Laaksonen Pi, Nyman M, Salonen J, Linder MB, Hirvonen J. Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution. Molecular pharmaceutics. 2012;9:654-63. DOI |
21 | Jindal AB. The effect of particle shape on cellular interaction and drug delivery applications of micro-and nanoparticles. International journal of pharmaceutics. 2017;532:450-65. DOI |
22 | Decuzzi P, Godin B, Tanaka T, Lee SY, Chiappini C, Liu X, Ferrari M. Size and shape effects in the biodistribution of intravascularly injected particles. Journal of Controlled Release. 2010;141:320-7. DOI |
23 | Looney MR, Bhattacharya J. Live imaging of the lung. Annual review of physiology. 2014;76:431-45. DOI |
24 | Yu T, Greish K, McGill LD, Ray A, Ghandehari H. Influence of geometry, porosity and surface characteristics of silica nanoparticles on acute toxicity: their vasculature effect and tolerance threshold. ACS nano. 2012;6:2289-301. DOI |
25 | Park JY, Park S, Lee TS, Hwang YH, Kim JY, Kang WJ, Key J. Biodegradable micro-sized discoidal polymeric particles for lung-targeted delivery system. Biomaterials. 2019;218:119331, doi:10.1016/j.biomaterials.2019.119331. DOI |
26 | Mak WC, Richter H, Patzelt A, Sterry W, Lai KK, Renneberg R, Lademann J. Drug delivery into the skin by degradable particles. European journal of pharmaceutics and biopharmaceutics. 2011;79:23-7. DOI |
27 | Liu Y, Miyoshi H, Nakamura M. Novel drug delivery system of hollow mesoporous silica nanocapsules with thin shells: preparation and fluorescein isothiocyanate (FITC) release kinetics. Colloids and Surfaces B: Biointerfaces. 2007;58:180-7. DOI |